Tiedemann Wealth Management LLC increased its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 19.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,592 shares of the pharmacy operator’s stock after purchasing an additional 2,215 shares during the quarter. Tiedemann Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $599,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Walgreens Boots Alliance by 2.8% during the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after acquiring an additional 1,926,108 shares in the last quarter. Franklin Resources Inc. increased its holdings in Walgreens Boots Alliance by 24.7% during the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after acquiring an additional 3,662,302 shares in the last quarter. Nordea Investment Management AB increased its holdings in Walgreens Boots Alliance by 1.0% during the 3rd quarter. Nordea Investment Management AB now owns 10,182,388 shares of the pharmacy operator’s stock valued at $786,284,000 after acquiring an additional 96,552 shares in the last quarter. CI Global Investments Inc. increased its holdings in Walgreens Boots Alliance by 4.8% during the 2nd quarter. CI Global Investments Inc. now owns 5,931,592 shares of the pharmacy operator’s stock valued at $464,503,000 after acquiring an additional 270,182 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Walgreens Boots Alliance by 14.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,905,909 shares of the pharmacy operator’s stock worth $462,500,000 after buying an additional 741,875 shares in the last quarter. Institutional investors and hedge funds own 61.18% of the company’s stock.
WBA has been the subject of a number of recent research reports. Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a report on Monday, December 4th. They set a “hold” rating and a $78.00 price target for the company. Raymond James Financial reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. Leerink Swann downgraded shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 1st. Loop Capital set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Thursday, October 26th. Finally, SunTrust Banks set a $72.00 price target on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Sunday, October 15th. Nine investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $86.20.
Walgreens Boots Alliance Inc (NASDAQ WBA) traded up $0.69 on Friday, hitting $76.07. 6,458,366 shares of the company traded hands, compared to its average volume of 6,450,000. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $88.00. The firm has a market capitalization of $75,340.00, a PE ratio of 21.01, a PEG ratio of 1.28 and a beta of 1.22.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The business had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. During the same period last year, the company earned $1.10 earnings per share. The company’s quarterly revenue was up 7.9% on a year-over-year basis. research analysts expect that Walgreens Boots Alliance Inc will post 5.67 earnings per share for the current year.
Walgreens Boots Alliance declared that its Board of Directors has authorized a share repurchase plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company’s leadership believes its stock is undervalued.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director John Anthony Lederer purchased 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The shares were acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the transaction, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION WARNING: “Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Bought by Tiedemann Wealth Management LLC” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/13/walgreens-boots-alliance-inc-wba-shares-bought-by-tiedemann-wealth-management-llc.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.